UPDATE ON ACCESS TO SURGICAL CARE SYSTEMS IN CANADA

TORONTO – April 24, 2013 — Since the early 2000s improving access to surgical and other hospital based care has been a national, provincial and regional priority across the country. Federal and provincial governments have allocated hundreds of millions of dollars to improve Canada’s weak performance in this area relative to other developed countries. Despite this investment, Canada continues to lag most other OECD countries in providing timely access to care.

Understanding that you can’t manage what you can’t track, many provincial government ministries of health have established provincial wait list registries. Each patient’s wait is tracked by these registries. Many of these provincial registries require the physician offices to submit paper forms or to log into a provincial web site in a parallel process outside the process of care. The timeliness and accuracy of capturing information by this approach has resulted in unnecessary costs and raised data integrity questions. MORE>>

P&P OPTICA INVITED TO CIC FOR THE CTA PROGRAM, ONE OF EIGHT CANADIAN LIFE SCIENCE COMPANIES CHOSEN TO PARTICIPATE

WATERLOO, Ontario, March 13, 2013 /PRNewswire/ — P&P Optica Inc., a world leader in the design, development and manufacture of high-performance optical spectrometers, has been selected as one of eight Canadian companies to participate in the Canadian Technology Accelerator (CTA) program in Boston. This intensive three-month program at the Cambridge Innovation Centre (CIC), launched by Gerald Keddy , Parliamentary Secretary to the Minister of International Trade, provides the selected companies with unique resources in the Boston Area, as well as mentoring by business leaders, trade commission advisers, and venture capitalists. The program aims to “grow innovative Canadian life science companies in a global commercialization hub” while also enabling new partnerships with companies based in the New England area. MORE>>

RNA DIAGNOSTICS RECEIVES FEDERAL GOVERNMENT FUNDING FOR BREAST CANCER TECHNOLOGY

TORONTO, ON – Feb 19, 2013 – Rna Diagnostics (RnaDx) received $462,500 today from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario).

Through FedDev Ontario’s Investing in Business Innovation initiative, Rna Diagnostics Inc. will receive a repayable contribution of up to $462,500 to prepare their diagnostic test, RNA Disruption Assay™ (RDA™), for commercial launch in European markets. The company expects to create more than 13 full-time jobs during the course of this project, with additional jobs as the company enters North American markets.

The funding was announced at the Conference Board of Canada’s Business innovation Summit in Toronto today by the Honourable Gary Goodyear, Minister of State for FedDev Ontario. MORE>>

CORNWALL COMMUNITY HOSPITAL TO IMPLEMENT NOVARI ACCESS TO CARE SYSTEM

CORNWALL, ON – Feb 11, 2013 : The Cornwall Community Hospital (CCH) is the first site within the Champlain LHIN to move to an integrated surgical eBooking, wait list management and automated provincial wait times reporting system. The browser based Novari Access to Care(tm) solution was selected to improve patient access to care by providing individual physician offices with a state of the art wait list management and eBooking system.

At the completion of the approximately three month implementation project, CCH will be among a growing number of Canadian hospitals, health authorities and LHINs to have implemented the Novari solution. Novari believes an important element in its selection at CCH was its proven ability to integrate with operating room and enterprise scheduling systems, as CCH information technology’s roadmap includes progress in these areas. The Novari system is the only one of its kind.

The growth of Novari Access to Care installations in three provinces and strong interest from across the country, continues at a brisk pace. The success of the system rests on its ability to provide value to the physician offices in managing their wait lists, paperless eBooking and removing the burden associated with reporting each case to the local provincial wait time registry. This is compounded by providing value to the hospitals by improving workflows, reducing costs and integrating with a host of OR scheduling systems. MORE>>

PPO HYPERCHANNEL SPECTROMETER NAMED 2012 PRISM AWARDS FINALIST IN DEFENSE AND SECURITY CATEGORY

WATERLOO, Ontario, Nov. 27, 2012 — /PRNewswire/ — P&P Optica Inc., a world leader in the development of high performance optical spectrometers, has been named a 2012 Prism Awards Finalist by SPIE for the PPO HyperChannel System in the category of Defense and Security. The winners will be announced at a gala banquet known as the “Oscars of Photonics,” in February 2013 at Photonics West. “The PPO HyperChannel is a natural complement to the defense and security industry’s arsenal of high quality, high performance optical products,” says CEO Olga Pawluczyk. P&P Optica remains committed to being a provider of high tech solutions for defense applications.  MORE>>